Predictors of mortality in patients with chronic kidney disease and an implantable defibrillator: An EPGEN substudy

Europace

Volumn 13, Issue 12, 2011, Pages 1717-1722

  Williams, Eric S ^a   Shah, Svati H ^a   Piccini, Jonathan P ^a   Sun, Albert Y ^a   Koontz, Jason I ^a   Al Khatib, Sana M ^a   Hranitzky, Patrick M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Chronic kidney disease; Implantable cardioverterdefibrillator; Mortality

Indexed keywords

AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DEFIBRILLATOR; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART DEATH; HEART EJECTION FRACTION; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MORTALITY; PRIORITY JOURNAL;

AGE FACTORS; AGED; ARRHYTHMIAS, CARDIAC; CHRONIC DISEASE; COHORT STUDIES; COMORBIDITY; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HEART VENTRICLES; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY DISEASES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STROKE VOLUME; SURVIVAL RATE;

EID: 81855206179     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eur253     Document Type: Article

References (23)

1. Collins AJ, Foley RN, Herzog C, Chavers BM, Gilbertson D, Ishani A et al. Excerpts from the US Renal Data System 2009 annual data report. Am J Kidney Dis 2010;55:S1-420. A426-427.
2. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P et al. Prevalence of chronic kidney disease in the United States. JAMA 2007;298:2038-47. (Pubitemid 350074801)
3. Herzog CA, Mangrum JM, Passman R. Sudden cardiac death and dialysis patients. Semin Dial 2008;21:300-7.
4. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-37. (Pubitemid 40110811)
5. Pun PH, Smarz TR, Honeycutt EF, Shaw LK, Al-Khatib SM, Middleton JP. Chronic kidney disease is associated with increased risk of sudden cardiac death among patients with coronary artery disease. Kidney Int 2009;76:652-8.
6. Deo R, Lin F, Vittinghoff E, Tseng ZH, Hulley SB, Shlipak MG. Kidney dysfunction and sudden cardiac death among women with coronary heart disease. Hypertension 2008;51:1578-82.
7. Zipes DP, Wyse DG, Friedman PL, Epstein AE, Hallstrom AP, Greene HL et al. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The antiarrhythmics versus implantable defibrillators (AVID) investigators. N Engl J Med 1997;337: 1576-83.
8. Connolly SJ, Hallstrom AP, Cappato R, Schron EB, Kuck KH, Zipes DP et al. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs implantable defibrillator study. Cardiac arrest study hamburg. Canadian implantable defibrillator study. Eur Heart J 2000;21:2071-8.
9. Cuculich PS, Sanchez JM, Kerzner R, Greenberg SL, Sengupta J, Chen J et al. Poor prognosis for patients with chronic kidney disease despite ICD therapy for the primary prevention of sudden death. Pacing Clin Electrophysiol 2007;30:207-13. (Pubitemid 46333676)
10. Korantzopoulos P, Liu T, Li L, Goudevenos JA, Li G. Implantable cardioverter defi-brillator therapy in chronic kidney disease: A meta-analysis. Europace 2009;11: 1469-75.
11. Sakhuja R, Keebler M, Lai TS, McLaughlin Gavin C, Thakur R, Bhatt DL. Meta-analysis of mortality in dialysis patients with an implantable cardioverter defibrillator. Am J Cardiol 2009;103:735-41.
12. Turakhia MP, Varosy PD, Lee K, Tseng ZH, Lee R, Badhwar N et al. Impact of renal function on survival in patients with implantable cardioverter- defibrillators. Pacing Clin Electrophysiol 2007;30:377-84. (Pubitemid 46426556)
13. Goldenberg I, Moss AJ, McNitt S, Zareba W, Andrews ML, Hall WJ et al. Relations among renal function, risk of sudden cardiac death, and benefit of the implanted cardiac defibrillator in patients with ischemic left ventricular dysfunction. Am J Cardiol 2006;98:485-90. (Pubitemid 44162874)
14. Blumer J, Wolber T, Hellermann J, Holzmeister J, Binggeli C, Duru F et al. Predictors of appropriate implantable cardioverter-defibrillator therapy during long-term follow-up of patients with coronary artery disease. Int Heart J 2009;50: 313-21.
15. Koontz JI, Haithcock D, Cumbea V, Waldron A, Stricker K, Hughes A et al. Rationale and design of the Duke electrophysiology genetic and genomic studies (EPGEN) biorepository. Am Heart J 2009;158:719-25.
16. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of diet in renal disease study group. Ann Intern Med 1999;130:461-70. (Pubitemid 29135798)
17. Chonchol M, Goldenberg I, Moss AJ, McNitt S, Cheung AK. Risk factors for sudden cardiac death in patients with chronic renal insufficiency and left ventricular dysfunction. Am J Nephrol 2007;27:7-14. (Pubitemid 46364535)
18. Desai H, Aronow WS, Ahn C, Tsai FS, Lai HM, Gandhi K et al. Incidence of appropriate cardioverter-defibrillator shocks and mortality in patients with heart failure treated with combined cardiac resynchronization plus implantable cardioverter-defibrillator therapy versus implantable cardioverter-defibrillator therapy. J Cardiovasc Pharmacol Ther 2010;15:37-40.
19. Hreybe H, Ezzeddine R, Bedi M, Barrington W, Bazaz R, Ganz LI et al. Renal insufficiency predicts the time to first appropriate defibrillator shock. Am Heart J 2006; 151:852-6.
20. Levy R, DellaValle A, Atav AS, Rehman A, Sklar AH, Stamato NJ. The relationship between glomerular filtration rate and survival in patients treated with an implantable cardioverter defibrillator. Clin Cardiol 2008;31:265-9. (Pubitemid 351961237)
21. Cheema A, Singh T, Kanwar M, Chilukuri K, Maria V, Saleem F et al. Chronic kidney disease and mortality in implantable cardioverter-defibrillator recipients. Cardiol Res Pract 2010;2010:Article ID 989261, doi:10.4061/2010/ 989261.
22. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351:1296-1305.
23. Agarwal R, Bunaye Z, Bekele DM, Light RP. Competing risk factor analysis of end-stage renal disease and mortality in chronic kidney disease. Am J Nephrol 2008;28: 569-75. (Pubitemid 351832443)